Top

Published in:

01-04-2022 | Antidepressant Drugs | Original Article

Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression

Authors: Haitham S. Mohammed, Yasser A. Khadrawy

Published in: Lasers in Medical Science | Issue 3/2022

Abstract

The present study aimed at investigating the antidepressant and antioxidant actions of near-infrared (NIR) laser at a wavelength of 830 nm and power of 100 mW which applied transcranially on an animal model of depression induced by repeated doses of reserpine (0.2 mg/kg). Thirty male Wistar adult rats were divided into three groups: rat model of depression; rat model of depression irradiated with laser for 14 days after induction of depression; and the control group that was given the drug vehicle and sham-exposed to the laser. Forced swimming test (FST) was used to verify the induction of animal model of depression and to screen the effect of antidepressant effect of low-level laser at the end of the experiment. Monoamine level, oxidative stress markers, and activities of acetylcholinesterase (AchE) and monoamine oxidase (MAO) were determined in the cortex and hippocampus of the rat brain. Reserpine resulted in depletion of monoamines and elevation in the oxidative stress markers and change in the enzymatic activities measured in both brain areas. Laser irradiation has an inhibitory action on the monoamine oxidase (MAO) in the cortex and hippocampus leading to elevation of the monoamine levels and attenuation of the oxidative stress in the studied areas. FST has emphasized the antidepressant effect of the utilized laser irradiation parameters on the behavioral level. The present findings provide evidence for the antidepressant and antioxidant actions of NIR low-power laser in the rat model of depression. Accordingly, low-laser irradiation may be presented as a potential candidate modality for depression treatment.

Golovynskyi S, Golovynska I, Stepanova LI, Datsenko OI, Liu L, Qu J, Ohulchanskyy TY (2018) Optical windows for head tissues in near-infrared and short-wave infrared regions: approaching transcranial light applications. J Biophotonics 11(12):e201800141CrossRef

Oron A, Oron U, Streeter J, De Taboada L, Alexandrovich A, Trembovler V, Shohami E (2007) Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 24(4):651–656CrossRef

Karu TI (2008) Mitochondrial signaling in mammalian cells activated by red and near-IR radiation. Photochem Photobiol 84:1091–1099CrossRef

Wang X, Tian F, Soni S, Gonzalez-Lima F, Liu H (2016) Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep 6:30540. https://doi.org/10.1038/srep30540CrossRefPubMedPubMedCentral

Lapchak PA (2012) Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases. Expert Rev Med Devices 9(1):71–83. https://doi.org/10.1586/erd.11.64CrossRefPubMedPubMedCentral

Schiffer F, Johnston AL, Ravichandran C, Polcari A, Teicher MH, Webb RH, Hamblin MR (2009) Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct 5:46. https://doi.org/10.1186/1744-9081-5-46CrossRefPubMedPubMedCentral

Ikram H, Haleem DJ (2017) Repeated treatment with reserpine as a progressive animal model of depression. Pak J Pharm Sci 30(3):897–902PubMed

Ou X, Chen K, Shih JC (2006) Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proceed Nat Acad Sci 103(29):10923–10928. https://doi.org/10.1073/pnas.0601515103CrossRef

Khadrawy YA, Sawie HG, Hosny ENM, H.H. (2018) Assessment of the antidepressant effect of caffeine using rat model of depression induced by reserpine. Bull Natl Res Cent 42:36. https://doi.org/10.1186/s42269-018-0034-1CrossRef

10.

Ciarlone AE (1978) Further modification of a fluoromertric method for analyzing brain amines. Microchem J 23:9–12CrossRef

11.

Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383–388CrossRef

12.

Montgomery HAC, Dymock JF (1961) The determination of nitrite in water. Analyst 6:414–416

13.

Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888PubMed

14.

Gorun V, Proinov I, Baltescu V, Balaban G, Barzu O (1978) Modified Ellman procedure for assay of cholinesterase in crude-enzymatic preparations. Anal Biochem 86:324–326CrossRef

15.

Holt A, Sharman DS, Baker GB, Palcic AMM (1997) continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem 244:384–392CrossRef

16.

Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47(4):379–391CrossRef

17.

Antkiewicz-Michaluk L, Wasik A, Mozdzen E, Romanska I, Michaluk J (2014) Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat. Neurotox Res 26:85–98CrossRef

18.

Mohammed HS, Khadrawy YA, Monem AS, Amer HM, El-Sherbini TM, Abd MK, Rahman E (2018) Formulated curcumin nanoparticles mitigate brain oxidative stress induced by reserpine in rats. J Bionanosci 12:290–296CrossRef

19.

Mohammed HS (2016) Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats. Lasers Med Sci 31:1651–1656. https://doi.org/10.1007/s10103-016-2033-5CrossRefPubMed

20.

Eshaghi E, Sadigh- Eteghad S, Mohaddes G, Rasta SH (2019) Transcranial photobiomodulation prevents anxiety and depression via changing serotonin and nitric oxide levels in brain of depression model mice: a study of three different doses of 810 nm laser. Lasers Surg Med 51:634–642. https://doi.org/10.1002/lsm.23082CrossRefPubMed

21.

Bhatt S, Nagappa AN, Patil CR (2020) Role of oxidative stress in depression. Drug Discov Today 25(7):1270–1276. https://doi.org/10.1016/j.drudis.2020.05.001CrossRefPubMed

22.

Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D (2006) Elevated monoamine oxidase A levels in the brain An explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63(11):1209–1216CrossRef

23.

Perugi G, Pacchiarotti I, Mainardi C et al (2019) Patterns of response to antidepressants in major depressive disorder: drug resistance or worsening of depression are associated with a bipolar diathesis. Eur Neuropsychopharmacol 29:825–834CrossRef

24.

Wang RZ, Vashistha V, Kaur S, Houchens NW (2016) Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med 83(11):810–817CrossRef

25.

Schmermund L, Jurkaš V, Özgen FF, Barone GD, Büchsenschütz HC, Winkler CK, Schmidt S, Kourist R, Kroutil W (2019) Photo-biocatalysis: biotransformations in the presence of light. ACS Catal 9(5):4115–4144CrossRef

26.

König B, Kümmel S, Svobodová E, Cibulka R (2018) Flavin photocatalysis. Phys Sci Rev 3:20170168. https://doi.org/10.1515/psr-2017-0168CrossRef

27.

Kaczmarczyk M, Regen F, Heuser I, Bajbouj M, Hellmann-Regen J (2018) Inhibition of monoamine oxidase activity by repetitive transcranial magnetic stimulation: implications for inter-train interval and frequency. Eur Arch Psychiatry Clin Neurosci 270:119–126. https://doi.org/10.1007/s00406-018-0969-0CrossRefPubMed

28.

de Freitas LF, Hamblin MR (2016) Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron 22(3):7000417. https://doi.org/10.1109/JSTQE.2016.2561201CrossRefPubMedPubMedCentral

29.

Caldieraro MA, Cassano P (2019) Transcranial and systemic photobiomodulation for major depressive disorder: a systematic review of efficacy, tolerability and biological mechanisms. J Affect Disord 243:262–273. https://doi.org/10.1016/j.jad.2018.09.048CrossRefPubMed

30.

Xu Z, Guo X, Yang Y, Tucker D, Lu Y, Xin N, Zhang G, Yang L, Li J, Du X, Zhang Q, Xu X (2017) Low-level laser irradiation improves depression-like behaviors in mice. Mol Neurobiol 54(6):4551–4559. https://doi.org/10.1007/s12035-016-9983-2CrossRefPubMed

31.

Salehpour F, Ahmadian N, Rasta SH, Farhoudi M, Karimi P, Sadigh-Eteghad S (2017) Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose-induced aging mice. Neurobiol Aging 58:140–150. https://doi.org/10.1016/j.neurobiolaging.2017.06.025CrossRefPubMed

32.

Chen CN, Chang KC, Lin RF, Wang MH, Shih RL, Tseng HC, Soung HS, Tsai CC (2016) Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats. Behav Brain Res 305:198–211. https://doi.org/10.1016/j.bbr.2016.02.038CrossRefPubMed

33.

Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8(10):766–775CrossRef

34.

Janowsky DS, Davis JM, El-Yousef MK, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632–635CrossRef

35.

Saharia K, Arya U, Kumar R, Sahu R, Das CK, Gupta K, Dwivedi H, Subramaniam JR (2012) Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent Abeta proteotoxicity in Caenorhabditis elegans. Exp Gerontol 47(2):188–197CrossRef

36.

Davis KL, Berger PA, Hollister LE, Barchas JD (1978) Cholinergic involvement in mental disorders. Life Sci 22:1865–1871CrossRef

37.

Picciotto MR, Higley MJ, Mineur YS (2012) Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76(1):116–129CrossRef

38.

Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, Picciotto MR (2013) Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc Natl Acad Sci U S A 110(9):3573–3578. https://doi.org/10.1073/pnas.1219731110

39.

Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacol 121:66–72CrossRef

40.

Akhtar M, Pillai KK, Vohora D (2005) Effect of thioperamide on modified forced swimming test-induced oxidative stress in mice. Basic Clin Pharmacol Toxicol 97:218–221. https://doi.org/10.1111/j.1742-7843.2005.pto_140.xCrossRefPubMed

41.

Salehpour F, Cassano P, Rouhi N, Hamblin MR, De Taboada L, Farajdokht F, Mahmoudi J (2019) Penetration profiles of visible and near-infrared lasers and light-emitting diode light through the head tissues in animal and human species: a review of literature. Photobiomodul Photomed Laser Surg 37(10):581–595CrossRef

42.

Wang P, Li T (2019) Which wavelength is optimal for transcranial low-level laser stimulation? J Biophotonics 12:e201800173. https://doi.org/10.1002/jbio.201800173CrossRefPubMed

43.

Vogel DDS, Ortiz-Villatoro NN, de Freitas L et al (2021) Repetitive transcranial photobiomodulation but not long-term omega-3 intake reduces epileptiform discharges in rats with stroke-induced epilepsy. J Biophotonics 14:e202000287. https://doi.org/10.1002/jbio.202000287CrossRefPubMed

Title: Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression
Authors: Haitham S. Mohammed
Yasser A. Khadrawy
Publication date: 01-04-2022
Publisher: Springer London
Keywords: Antidepressant Drugs
Affective Disorder
Affective Disorder
Antidepressant Drugs
Laser
Published in: Lasers in Medical Science / Issue 3/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03410-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2022

Efficacy of ILIB on periodontal clinical parameters and glycemic control in patients with periodontitis and type II diabetes—randomized clinical trial

Association of photobiomodulation therapy and therapeutic exercises in relation to pain intensity and neck disability in individuals with chronic neck pain: a systematic review of randomized trials

Efficacy and safety comparison between 1927 nm thulium laser and 2940 nm Er:YAG laser in the treatment of facial atrophic acne scarring: a prospective, simultaneous spilt-face clinical trial

Beneficial effects of infrared light-emitting diode in corticosteroid-resistant asthma

Light transmittance dynamics and spectral absorption characteristics during auxiliary cryogen spray cooling in laser dermatology

Effectiveness of preconditioned adipose-derived mesenchymal stem cells with photobiomodulation for the treatment of diabetic foot ulcers: a systematic review